Oscar Health (NYSE:OSCR) Upgraded at Wall Street Zen

Oscar Health (NYSE:OSCR) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday.

Several other equities research analysts have also recently issued reports on OSCR. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research note on Thursday. Barclays set a $18.00 price target on Oscar Health and gave the stock an “equal weight” rating in a report on Monday, January 5th. UBS Group restated a “neutral” rating and issued a $15.00 price objective on shares of Oscar Health in a report on Wednesday. Stephens initiated coverage on shares of Oscar Health in a research report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price on the stock. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $16.88.

Oscar Health Price Performance

Shares of OSCR stock opened at $13.41 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. The company has a market capitalization of $3.55 billion, a PE ratio of -7.70 and a beta of 1.90. The firm’s 50-day moving average is $15.24 and its two-hundred day moving average is $16.69. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.80.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The firm had revenue of $2.76 billion during the quarter, compared to analysts’ expectations of $3.12 billion. Oscar Health had a negative net margin of 3.79% and a negative return on equity of 37.72%. The business’s quarterly revenue was up 17.3% on a year-over-year basis. During the same period last year, the company earned ($0.62) EPS. Analysts predict that Oscar Health will post 0.69 earnings per share for the current year.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 76,962 shares of Oscar Health stock in a transaction that occurred on Tuesday, January 6th. The shares were sold at an average price of $17.01, for a total value of $1,309,123.62. Following the completion of the transaction, the insider owned 350,180 shares in the company, valued at approximately $5,956,561.80. The trade was a 18.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Janet Liang sold 7,338 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $121,737.42. Following the sale, the insider directly owned 172,527 shares in the company, valued at approximately $2,862,222.93. The trade was a 4.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 197,125 shares of company stock valued at $3,265,300. Insiders own 24.39% of the company’s stock.

Institutional Trading of Oscar Health

A number of large investors have recently modified their holdings of the stock. Straightline Group LLC raised its stake in shares of Oscar Health by 3.7% in the second quarter. Straightline Group LLC now owns 18,082 shares of the company’s stock valued at $388,000 after acquiring an additional 640 shares in the last quarter. Wealthspire Advisors LLC increased its holdings in Oscar Health by 6.7% during the 2nd quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company’s stock worth $238,000 after purchasing an additional 700 shares during the period. OneDigital Investment Advisors LLC raised its position in Oscar Health by 0.6% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock valued at $2,617,000 after purchasing an additional 779 shares in the last quarter. Focus Partners Wealth raised its position in Oscar Health by 1.4% in the 3rd quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after purchasing an additional 824 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Oscar Health by 14.4% in the 2nd quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company’s stock valued at $153,000 after buying an additional 900 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.